Intravitreal photoswitch therapy in advanced retinitis pigmentosa: a phase 1 open-label trial

A first-in-human phase 1 trial shows that intravitreal photoswitch therapy can be administered safely in advanced retinitis pigmentosa, with exploratory signals compatible with light responsiveness following treatment.